EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method

Afsaneh Emamiamin, Seyedeh Rojin Shariati Pour iD, Thea Serra iD, Donato Calabria iD, Marta Varone, Fabio Di Nardo iD, Massimo Guardigli, Laura Anfossi iD, Claudio Baggiani iD, Martina Zangheri iD, Mara Mirasoli iD

Biosensors · 2025

DOI: 10.3390/bios15040238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Afsaneh Emamiamin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Tecnopolo di Rimini, Via Dario Campana 71, I-47922 Rimini, …. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Early Detection of Cancer, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research: PRIN 2022, Unione Europea—Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs), which circulate in the serum and plasma, play a role in several biological processes, and their levels in body fluids are associated with the pathogenesis of various diseases, including different types of cancer. For this reason, miRNAs are considered promising candidates as biomarkers for diagnostic purposes, enabling the early detection of pathological onset and monitoring drug responses during therapy. However, current methods for miRNA quantification, such as northern blotting, isothermal amplification, RT-PCR, microarrays, and next-generation sequencing, are limited by their reliance on centralized laboratories, high costs, and the need for specialized personnel. Consequently, the development of sensitive, simple, and one-step analytical techniques for miRNA detection is highly desirable, particularly given the importance of early diagnosis and prompt treatment in cases of cancer. Lateral flow assays (LFAs) are among the most attractive point-of-care (POC) devices for healthcare applications. These systems allow for the rapid and straightforward detection of analytes using low-cost setups that are accessible to a wide audience. This review focuses on LFA-based methods for detecting and quantifying miRNAs associated with the diagnosis of various cancers, with particular emphasis on sensitivity enhancements achieved through the application of different labels and detection systems. Early, non-invasive detection of these diseases through the quantification of tailored biomarkers can significantly reduce mortality, improve survival rates, and lower treatment costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsEarly Detection of CancerBiosensing TechniquesHumansBiomarkers, Tumor

Stichwörter der Autor:innen

biosensorcancerlateral flow assaymicroRNApoint-of-care

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Tecnopolo di Rimini, Via Dario Campana 71, I-47922 Rimini, Italy.
  • Department of Chemistry, University of Turin, Via P. Giuria 5, I-10125 Turin, Italy.
  • Department of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Via Francesco Selmi 2, I-40126 Bologna, Italy.
  • Interdepartmental Centre for Industrial Aerospace Research (CIRI AEROSPACE), Alma Mater Studiorum-University of Bologna, Via Baldassarre Canaccini 12, I-47121 Forlì, Italy.
  • Interdepartmental Centre for Industrial Research in Renewable Resources, Environment, Sea, and Energy (CIRI FRAME), Alma Mater Studiorum-University of Bologna, Via St. Alberto 163, I-48123 Ravenna, Italy.
  • Interdepartmental Centre for Industrial Agrofood Research (CIRI AGRO), Alma Mater Studiorum-University of Bologna, Via Quinto Bucci 336, I-47521 Cesena, Italy.

ORCID-Profile: Seyedeh Rojin Shariati Pour, Thea Serra, Donato Calabria, Fabio Di Nardo, Laura Anfossi, Claudio Baggiani, Martina Zangheri, Mara Mirasoli

Förderung

  • Italian Ministry of University and Research: PRIN 2022
  • Unione Europea—Next Generation EU

Zitieren

APA

Emamiamin, A., Shariati Pour, S. R., Serra, T., Calabria, D., Varone, M., Di Nardo, F., Guardigli, M., Anfossi, L., Baggiani, C., Zangheri, M., & Mirasoli, M. (2025). New Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method. Biosensors. https://doi.org/10.3390/bios15040238

Vancouver

Emamiamin A, Shariati Pour SR, Serra T, Calabria D, Varone M, Di Nardo F, et al. New Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method. Biosensors. 2025. doi:10.3390/bios15040238

BibTeX
@article{Emamiamin2025,
  author = {Emamiamin, Afsaneh and Shariati Pour, Seyedeh Rojin and Serra, Thea and Calabria, Donato and Varone, Marta and Di Nardo, Fabio and Guardigli, Massimo and Anfossi, Laura and Baggiani, Claudio and Zangheri, Martina and Mirasoli, Mara},
  title = {New Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15040238}
}
Kostenlos starten →